Pdt Partners, LLC Uni Qure N.V. Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

A detailed history of Pdt Partners, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Pdt Partners, LLC holds 57,199 shares of QURE stock, worth $386,093. This represents 0.03% of its overall portfolio holdings.

Number of Shares

57,199

Previous 139,001 58.85%

Holding current value

$386,093

Previous $622,000 54.82%

% of portfolio

0.03%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.78 - $10.12 $309,211 - $827,836	-81,802 Reduced 58.85%	57,199 $281,000
Q2 2024 Aug 15, 2024	BUY	$4.39 - $5.43 $75,227 - $93,048	17,136 Added 14.06%	139,001 $622,000
Q1 2024 May 15, 2024	BUY	$4.82 - $6.93 $104,420 - $150,131	21,664 Added 21.62%	121,865 $633,000
Q4 2023 Feb 14, 2024	SELL	$5.63 - $8.27 $168,415 - $247,388	-29,914 Reduced 22.99%	100,201 $678,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $11.83 $229,065 - $403,852	34,138 Added 35.57%	130,115 $873,000
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $359,987 - $718,680	32,373 Added 50.9%	95,977 $1.1 Million
Q1 2023 May 15, 2023	BUY	$18.7 - $23.07 $789,196 - $973,623	42,203 Added 197.2%	63,604 $1.28 Million
Q4 2022 Feb 14, 2023	BUY	$18.12 - $27.32 $387,786 - $584,675	21,401 New	21,401 $485,000
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $178,918 - $278,242	-13,606 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$14.54 - $21.5 $24,180 - $35,754	-1,663 Reduced 10.89%	13,606 $246,000
Q4 2021 Feb 14, 2022	BUY	$20.24 - $36.01 $309,044 - $549,836	15,269 New	15,269 $317,000
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $491,348 - $706,272	-16,804 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$35.35 - $50.67 $594,021 - $851,458	16,804 New	16,804 $607,000
Q3 2018 Nov 14, 2018	SELL	$29.75 - $43.08 $526,575 - $762,516	-17,700 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$21.96 - $39.94 $2.58 Million - $4.69 Million	-117,400 Reduced 86.9%	17,700 $669,000
Q1 2018 May 15, 2018	SELL	$17.1 - $26.61 $67,801 - $105,508	-3,965 Reduced 2.85%	135,100 $3.18 Million
Q4 2017 Feb 14, 2018	BUY	$9.47 - $19.59 $1.32 Million - $2.72 Million	139,065	139,065 $2.72 Million

Others Institutions Holding QURE

# of Institutions

151

Shares Held

41.2M

Call Options Held

891K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $315M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account